These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents. Penta A; Franzblau S; Wan B; Murugesan S Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570 [TBL] [Abstract][Full Text] [Related]
4. Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents. Cappoen D; Jacobs J; Nguyen Van T; Claessens S; Diels G; Anthonissen R; Einarsdottir T; Fauville M; Verschaeve L; Huygen K; De Kimpe N Eur J Med Chem; 2012 Feb; 48():57-68. PubMed ID: 22182928 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336 [TBL] [Abstract][Full Text] [Related]
7. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives. Patel KN; Telvekar VN Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490 [TBL] [Abstract][Full Text] [Related]
9. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones. Kamal A; Shetti RV; Azeeza S; Swapna P; Khan MN; Khan IA; Sharma S; Abdullah ST Eur J Med Chem; 2011 Mar; 46(3):893-900. PubMed ID: 21272965 [TBL] [Abstract][Full Text] [Related]
10. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis. Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334 [TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of bisbenzaldehydes against four Mycobacterium species. Cappoen D; Forge D; Vercammen F; Mathys V; Kiass M; Roupie V; Anthonissen R; Verschaeve L; Vanden Eynde JJ; Huygen K Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives. Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188 [TBL] [Abstract][Full Text] [Related]
14. Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies. Pancholia S; Dhameliya TM; Shah P; Jadhavar PS; Sridevi JP; Yogeshwari P; Sriram D; Chakraborti AK Eur J Med Chem; 2016 Jun; 116():187-199. PubMed ID: 27061982 [TBL] [Abstract][Full Text] [Related]
15. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives. Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097 [TBL] [Abstract][Full Text] [Related]
17. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis. Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928 [TBL] [Abstract][Full Text] [Related]
18. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents. Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis. Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]